Who Owns Yarrow Bioscience Stock?
NASDAQ: YARWHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 38.23%
- Held by insiders
- 2.02%
- Institutional holders
- 51
- Institutions 38.2%
- Insiders 2.0%
- Public and other 59.8%
Who owns Yarrow Bioscience stock?
Institutional investors own about 38.2% of Yarrow Bioscience's shares, spread across 51 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 2.02% of YARW.
The largest institutional holders are Adar1 Capital Management, LLC (2.21%), Staley Capital Advisers, Inc. (1.93%) and Nantahala Capital Management, LLC (1.50%). Together, the top 10 institutions control 10.8% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their YARW positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of YARW
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Adar1 Capital Management, LLC | 59.00K | 2.21% | +177.3% |
| Staley Capital Advisers, Inc. | 51.47K | 1.93% | +4902.1% |
| Nantahala Capital Management, LLC | 40.00K | 1.50% | 0.0% |
| Lynx1 Capital Management Lp | 32.57K | 1.22% | 0.0% |
| Shay Capital LLC | 29.13K | 1.09% | -9.5% |
| Deeter Investments Llp | 20.00K | 0.75% | 0.0% |
| T3 Companies, LLC | 18.90K | 0.71% | 0.0% |
| Braidwell LP | 18.32K | 0.69% | 0.0% |
| Kvp Capital Advisors, LP | 10.01K | 0.37% | 0.0% |
| Citadel Advisors Llc | 9.37K | 0.35% | -8.9% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of YARW
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 5.29K | 0.20% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 2.84K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 694 | 0.03% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 427 | 0.02% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 74 | 0.00% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 7 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Yarrow Bioscience?
Adar1 Capital Management, LLC is the largest institutional shareholder of YARW, owning 2.21% of shares outstanding (59.00K shares) as of its latest 13F filing.
What percentage of Yarrow Bioscience is owned by institutions?
Institutions own about 38.2% of YARW shares and 39.0% of the public float.
How much of Yarrow Bioscience do insiders own?
Insiders, such as officers and directors, own about 2.02% of YARW shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.